Why the study?
Does intravenous verapamil restore sinus rhythm in supraventricular tachycardia and reduce ventricular rate in atrial fibrillation?
Does intravenous verapamil restore sinus rhythm in supraventricular tachycardia and reduce ventricular rate in atrial fibrillation?
Intravenous verapamil is an effective and generally safe antiarrhythmic agent for terminating supraventricular tachycardia and controlling ventricular rate in atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for IV verapamil in SVT termination; prospective trials needed before clinical adoption.
Verapamil administered by the intravenous route restored sinus rhythm in 33 out of 40 episodes of supraventricular tachycardia. The drug was also effective in reducing ventricular rate in patients with atrial fibrillation. Intracardiac conduction studies using His bundle electrograms showed prolongation of atrioventricular nodal conduction in eight out of nine cases after 5 mg of verapamil were given. The distal conduction was unaffected. Bradycardia and hypotension occurred in two cases and responded promptly to intravenous administration of atropine. Verapamil is an effective antiarrhythmic agent which is, in general, free from significant side effects.
No takes yet. Share an insight, caveat, or question.
Vohra et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: